Bone Graft
-
Biologics
Cerapedics Announces FDA approval of an IDE supplement
WESTMINSTER, Colo., July 22, 2020 — Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA)…
Read More » -
Regulatory
Medtronic pulls Infuse bone graft from Australia
June 30, 2020 / Alan Condon Medtronic has withdrawn its Infuse Bone Graft/LT-Cage Lumbar Tapered Fusion device from the Australian…
Read More » -
Biologics
SIRAKOSS Receives U.S. FDA 510(k) Clearance for Osteo3 ZP Putty to Catalyse Rapid and Complete Bone Regeneration
Aberdeen, UK, 17 June 2020 – SIRAKOSS Ltd, a developer of nanosynthetic bone graft substitutes, announced today that it has received…
Read More » -
Biologics
Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
WESTMINSTER, Colo., May 19, 2020 /PRNewswire/ — Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide…
Read More » -
Biologics
Randomized Controlled Trial Results Published in ‘Spine’ Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion
– Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
In2Bones Introduces CoLink® Bone Graft Harvester And Tribio™ Backfill Plugs
November 05, 2019 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announced the U.S. commercial launch of its CoLink® Bone Graft Harvester and Tribio™ Backfill Plugs System.…
Read More » -
Biologics
Biogennix Launches Agilon Bone Grafting Solution
September 04, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Camber Spine Announces Addition of Biologics to Its Portfolio
KING OF PRUSSIA, Pa., Aug. 7, 2019 /PRNewswire/ — Camber Spine, a leading innovator in spine and medical technologies, today announced that it…
Read More » -
Hospitals
Amedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device
SALT LAKE CITY, November 10, 2015 – Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform,…
Read More » -
Hospitals
Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery
WESTMINSTER, Colo., Nov. 3, 2015 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved…
Read More » -
Biologics
Biodegradable polymer could help heal the bones of patients with orthopedic injuries
A plastic derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds…
Read More » -
Hospitals
Wright Medical’s bone graft receives FDA approval: 5 observations
By Anuja Vaidya Wright Medical’s Augment Bone Graft product received FDA approval. Here are five observations: 1. The product is an alternative…
Read More » -
Biologics
BIOMATLANTE Obtains CE Approval to Market EZ Cure Plug and Strip
BIOMATLANTE (Vigneux de Bretagne), a medical device company specialized in bone regeneration, today announced the CE regulatory approval of EZ…
Read More » -
Biologics
Cerapedics uses silk from a moth to create new spine bone graft
Biloine W. Young • Thu, February 5th, 2015 Cerapedics, Inc., a privately-held orthobiologics company located in Westminster, Colorado, has received…
Read More »